キッズウェル・バイオ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4584/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/03/01 | 日証協 | 346,888株 | -23.67% | 31,576株 | -31.49% | 806,931株 | -4.63% | 33,400株 | -36.86% |
2019/02/22 | 日証協 | 454,488株 | -19.9% | 46,088株 | +115.26% | 846,066株 | -3.07% | 52,900株 | +119.5% |
2019/02/15 | 日証協 | 567,400株 | -16.37% | 21,410株 | -87.45% | 872,860株 | -3.07% | 24,100株 | -88.63% |
2019/02/08 | 日証協 | 678,490株 | -2.39% | 170,600株 | -8.68% | 900,460株 | +9.09% | 212,006株 | +30.7% |
2019/02/01 | 日証協 | 695,078株 | +1.41% | 186,825株 | +37.78% | 825,434株 | +0.24% | 162,212株 | +70.37% |
2019/01/25 | 日証協 | 685,400株 | +6.76% | 135,600株 | +165.49% | 823,467株 | +7.13% | 95,211株 | +283.71% |
2019/01/18 | 日証協 | 641,988株 | -7.61% | 51,076株 | +44.28% | 768,669株 | -6.3% | 24,813株 | -20.76% |
2019/01/11 | 日証協 | 694,900株 | -1.25% | 35,400株 | +436.36% | 820,356株 | +1.55% | 31,312株 | +878.5% |
2019/01/04 | 日証協 | 703,700株 | +1.03% | 6,600株 | -95.05% | 807,856株 | -0.53% | 3,200株 | -88.49% |
2018/12/28 | 日証協 | 696,500株 | +9.55% | 133,200株 | +16.19% | 812,156株 | -0.95% | 27,802株 | +3.74% |
2018/12/21 | 日証協 | 635,800株 | +11.5% | 114,640株 | +45.99% | 819,954株 | +4.81% | 26,800株 | -56.91% |
2018/12/14 | 日証協 | 570,200株 | +19.52% | 78,528株 | -24.2% | 782,342株 | +5.7% | 62,200株 | +62.3% |
2018/12/07 | 日証協 | 477,088株 | -10.13% | 103,600株 | +24.52% | 740,142株 | -6.48% | 38,324株 | -65.2% |
2018/11/30 | 日証協 | 530,888株 | -0.66% | 83,200株 | +116.22% | 791,442株 | +12.24% | 110,112株 | +619.12% |
2018/11/22 | 日証協 | 534,440株 | +1.08% | 38,480株 | -60.67% | 705,142株 | +3.78% | 15,312株 | -82.46% |
2018/11/16 | 日証協 | 528,740株 | -10.6% | 97,840株 | -6.5% | 679,442株 | -24.27% | 87,300株 | +61.97% |
2018/11/09 | 日証協 | 591,440株 | -8.98% | 104,640株 | +96.69% | 897,153株 | -3.91% | 53,900株 | +146.11% |
2018/11/02 | 日証協 | 649,800株 | +8.98% | 53,200株 | -53.82% | 933,653株 | +1.94% | 21,901株 | -72.62% |
2018/10/26 | 日証協 | 596,267株 | -12.93% | 115,200株 | +26.16% | 915,852株 | -0.68% | 80,000株 | +540% |
※株式分割は考慮していませんのでご注意ください。
Page Top